Vericel Corporation (VCEL)

$33.53 +2.22 (7.09%)
Market Cap 1.58B
Revenue (ttm) 237.22M
Net Income (ttm) 10.36M
EPS (ttm) N/A
PE Ratio 271.17
Forward PE 165.46
Profit Margin 4.37%
Debt to Equity Ratio 0.00
Volume 1,839,000
Avg Vol 631,422
Day's Range N/A - N/A
Shares Out 50.46M
Stochastic %K 50%
Beta 1.33
Analysts Strong Sell
Price Target $53.88

Company Profile

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 588 5555
Fax: 617 588 5554
Address:
64 Sidney Street, Cambridge, United States
LAMIGRA
LAMIGRA Sep. 10 at 6:13 PM
$VCEL management should be fired immediately lol
0 · Reply
copperhat
copperhat Sep. 10 at 5:55 PM
$VCEL holy crap
0 · Reply
Tjmaze
Tjmaze Sep. 10 at 5:53 PM
$VCEL one trick pony, competition is eating away at potential market share.
1 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 10 at 4:57 PM
$VCEL support is completely gone- into the 30's. outrageous and criminal.
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 10 at 4:12 PM
$VCEL oh look- low for the year. again.
0 · Reply
copperhat
copperhat Sep. 10 at 2:23 PM
$VCEL piece of degenerate shit
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 8 at 7:09 PM
$VCEL market up again- yet we wallow, down nearly 3% and poised to dip into the 32/share range. how freakin pitiful is this?
1 · Reply
copperhat
copperhat Sep. 8 at 3:41 PM
$VCEL depressing turd
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Sep. 7 at 2:18 PM
The attachment lists the change in share price for all comm'l-stage oncology (over $100MM market cap) & non-oncology (over $1B market cap) focused bios since Friday 8/22/2025. By 8/22/2025 virtually all bios in these peer groups had reported Q2 2025 sales & results of operations. The XBI is up just over 5% over the last 3 weeks (or 87% annualized). About 2 of every 3 bios in both peer groups are up which means 1 of every 3 are down. This is not investment advice but is it possible some of those who are down, excluding those like $SPRY with news, are oversold. Of course we could be wrong. $AUTL $TWST $VCEL $HRMY
2 · Reply
LAMIGRA
LAMIGRA Sep. 5 at 3:46 PM
$VCEL crazy to shave off this much value in my brokerage account after all this time investing in VCEL. And management seems to care zero… 🤯🤯🤯
0 · Reply
Latest News on VCEL
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025

Aug 28, 2025, 8:30 AM EDT - 14 days ago

Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025

Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 3:10 PM EDT - 6 weeks ago

Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript

Vericel Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 8:08 AM EDT - 6 weeks ago

Vericel Reports Second Quarter 2025 Financial Results

Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025

Jul 17, 2025, 8:30 AM EDT - 2 months ago

Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025

Vericel Corporation: Moving From Sell To Neutral

Jun 12, 2025, 10:23 AM EDT - 3 months ago

Vericel Corporation: Moving From Sell To Neutral

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

Jun 10, 2025, 8:30 AM EDT - 3 months ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

Vericel Corporation (VCEL) Q1 2025 Earnings Conference Call Transcript

May 8, 2025, 1:52 PM EDT - 4 months ago

Vericel Corporation (VCEL) Q1 2025 Earnings Conference Call Transcript

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

May 8, 2025, 7:55 AM EDT - 4 months ago

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

May 7, 2025, 8:30 AM EDT - 4 months ago

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 8:30 AM EDT - 5 months ago

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Vericel: Scalable Growth With Strong Margins

Mar 5, 2025, 11:56 PM EST - 6 months ago

Vericel: Scalable Growth With Strong Margins

Vericel to Present at Multiple Upcoming Investor Conferences

Mar 4, 2025, 8:30 AM EST - 6 months ago

Vericel to Present at Multiple Upcoming Investor Conferences

Vericel Corporation (VCEL) Q4 2024 Earnings Conference Call Transcript

Feb 27, 2025, 1:05 PM EST - 7 months ago

Vericel Corporation (VCEL) Q4 2024 Earnings Conference Call Transcript

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Feb 27, 2025, 7:54 AM EST - 7 months ago

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Feb 13, 2025, 8:30 AM EST - 7 months ago

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Jan 15, 2025, 8:52 AM EST - 8 months ago

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

APLD CVGW

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Jan 14, 2025, 4:05 PM EST - 8 months ago

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Vericel Corporation: Hard To Justify Current Valuation

Dec 19, 2024, 12:50 PM EST - 9 months ago

Vericel Corporation: Hard To Justify Current Valuation

Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript

Nov 7, 2024, 1:52 PM EST - 11 months ago

Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript

Vericel Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 7:55 AM EST - 11 months ago

Vericel Reports Third Quarter 2024 Financial Results

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Oct 24, 2024, 8:30 AM EDT - 11 months ago

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Aug 29, 2024, 9:17 AM EDT - 1 year ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Aug 26, 2024, 7:45 AM EDT - 1 year ago

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 15, 2024, 4:05 PM EDT - 1 year ago

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Aug 7, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 3:58 PM EDT - 1 year ago

Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript

Vericel Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 7:55 AM EDT - 1 year ago

Vericel Reports Second Quarter 2024 Financial Results

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Jul 22, 2024, 8:30 AM EDT - 1 year ago

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

Jun 11, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

May 22, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript

May 8, 2024, 2:36 PM EDT - 1 year ago

Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

May 8, 2024, 7:55 AM EDT - 1 year ago

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Apr 24, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 11:39 AM EST - 1 year ago

Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Feb 29, 2024, 7:55 AM EST - 1 year ago

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Feb 27, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Feb 15, 2024, 8:30 AM EST - 1 year ago

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Feb 5, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Jan 9, 2024, 7:55 AM EST - 1 year ago

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Jan 3, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 2:43 PM EST - 2 years ago

Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Nov 8, 2023, 7:55 AM EST - 2 years ago

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Vericel to Present at the Stephens Annual Investment Conference

Nov 7, 2023, 8:30 AM EST - 2 years ago

Vericel to Present at the Stephens Annual Investment Conference

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

Oct 25, 2023, 8:30 AM EDT - 2 years ago

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

Sep 28, 2023, 8:30 AM EDT - 2 years ago

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

Sep 20, 2023, 4:30 PM EDT - 2 years ago

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

Vericel to Present at the Morgan Stanley Global Healthcare Conference

Sep 6, 2023, 8:30 AM EDT - 2 years ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Aug 2, 2023, 7:55 AM EDT - 2 years ago

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

Jul 20, 2023, 8:30 AM EDT - 2 years ago

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

LAMIGRA
LAMIGRA Sep. 10 at 6:13 PM
$VCEL management should be fired immediately lol
0 · Reply
copperhat
copperhat Sep. 10 at 5:55 PM
$VCEL holy crap
0 · Reply
Tjmaze
Tjmaze Sep. 10 at 5:53 PM
$VCEL one trick pony, competition is eating away at potential market share.
1 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 10 at 4:57 PM
$VCEL support is completely gone- into the 30's. outrageous and criminal.
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 10 at 4:12 PM
$VCEL oh look- low for the year. again.
0 · Reply
copperhat
copperhat Sep. 10 at 2:23 PM
$VCEL piece of degenerate shit
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 8 at 7:09 PM
$VCEL market up again- yet we wallow, down nearly 3% and poised to dip into the 32/share range. how freakin pitiful is this?
1 · Reply
copperhat
copperhat Sep. 8 at 3:41 PM
$VCEL depressing turd
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Sep. 7 at 2:18 PM
The attachment lists the change in share price for all comm'l-stage oncology (over $100MM market cap) & non-oncology (over $1B market cap) focused bios since Friday 8/22/2025. By 8/22/2025 virtually all bios in these peer groups had reported Q2 2025 sales & results of operations. The XBI is up just over 5% over the last 3 weeks (or 87% annualized). About 2 of every 3 bios in both peer groups are up which means 1 of every 3 are down. This is not investment advice but is it possible some of those who are down, excluding those like $SPRY with news, are oversold. Of course we could be wrong. $AUTL $TWST $VCEL $HRMY
2 · Reply
LAMIGRA
LAMIGRA Sep. 5 at 3:46 PM
$VCEL crazy to shave off this much value in my brokerage account after all this time investing in VCEL. And management seems to care zero… 🤯🤯🤯
0 · Reply
copperhat
copperhat Sep. 5 at 12:18 PM
$VCEL I think it is time to cut my losses on this shit. uninspired conference presentation yesterday, forward p/e over 100. Gotta wonder where the analysts pull their pts from.
2 · Reply
gorwell
gorwell Sep. 4 at 9:14 PM
$VCEL made really good money on his a while back. Why is this price 473x earnings? 1x would be like penny stock territory?
0 · Reply
copperhat
copperhat Sep. 4 at 8:29 PM
$VCEL I guess post market doesn't like the conference
0 · Reply
copperhat
copperhat Sep. 4 at 8:17 PM
$VCEL the conference doesn't generate any huge inspiration
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 4 at 7:21 PM
$VCEL yet another day of failure- showed some life this morning, then shitter follows...
0 · Reply
asahi
asahi Sep. 3 at 5:42 PM
$VCEL solid shit show
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 3 at 4:16 PM
$VCEL the lack of anything at all from vcel shows that they really don't give a rip about shareholder value.
0 · Reply
copperhat
copperhat Sep. 3 at 3:53 PM
$VCEL another percent down
0 · Reply
copperhat
copperhat Sep. 2 at 7:24 PM
$VCEL is this a new yearly low? Should I just cut my losses?
1 · Reply
ceonner
ceonner Sep. 2 at 3:51 PM
$VCEL back in again 35.60 😂
1 · Reply
copperhat
copperhat Sep. 2 at 3:50 PM
$VCEL and another percent down
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 2 at 2:57 PM
$VCEL …blows.
0 · Reply